Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer

Cancer Letters

Volumn 221, Issue 2, 2005, Pages 185-190

  Sørensen, Mette ^a   Autrup, Herman ^b   Tjønneland, Anne ^a   Overvad, Kim ^c   Raaschou Nielsen, Ole ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CYP1B1; GSTA1; Lung cancer; NAT2; NQO1; Smoking

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1B1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 16244416871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.012     Document Type: Article

References (30)

1. S.D. Spivack, G.J. Hurteau, M.J. Fasco, and L.S. Kaminsky Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors Clin. Cancer Res. 9 2003 6002 6011
2. J.A. Agundez Cytochrome P450 gene polymorphism and cancer Curr. Drug Metab. 5 2004 211 224
3. T. Shimada, J. Watanabe, K. Kawajiri, T.R. Sutter, F.P. Guengerich, and E.M. Gillam Catalytic properties of polymorphic human cytochrome P450 1B1 variants Carcinogenesis 20 1999 1607 1613
4. J. Watanabe, T. Shimada, E.M. Gillam, T. Ikuta, K. Suemasu, and Y. Higashi Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer Pharmacogenetics 10 2000 25 33
5. M. Sorensen, H. Autrup, A. Tjonneland, K. Overvad, and O. Raaschou-Nielsen Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer Int. J. Cancer 110 2004 219 224
6. S. Anttila, A. Hirvonen, H. Vainio, K. Husgafvel-Pursiainen, J.D. Hayes, and B. Ketterer Immunohistochemical localization of glutathione S-transferases in human lung Cancer Res. 53 1993 5643 5648
7. B.F. Coles, F. Morel, C. Rauch, W.W. Huber, M. Yang, and C.H. Teitel Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression Pharmacogenetics 11 2001 663 669
8. B. Coles, S.A. Nowell, S.L. MacLeod, C. Sweeney, N.P. Lang, and F.F. Kadlubar The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk Mutat. Res. 482 2001 3 10
9. R.D. Traver, D. Siegel, H.D. Beall, R.M. Phillips, N.W. Gibson, and W.A. Franklin Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase) Br. J. Cancer 75 1997 69 75
10. S.J. Lewis, N.M. Cherry, R.M. Niven, P.V. Barber, and A.C. Povey Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population Lung Cancer 34 2001 177 183
11. H. Chen, A. Lum, A. Seifried, L.R. Wilkens, and L. le Marchand Association of the NAD(P)H:quinone oxidoreductase 609C->T polymorphism with a decreased lung cancer risk Cancer Res. 59 1999 3045 3048
12. K.F. Windmill, A. Gaedigk, P.M. Hall, H. Samaratunga, D.M. Grant, and M.E. McManus Localization of N-acetyltransferases NAT1 and NAT2 in human tissues Toxicol. Sci. 54 2000 19 29
13. F. Nyberg, S.M. Hou, K. Hemminki, B. Lambert, and G. Pershagen Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls Cancer Epidemiol. Biomarkers Prev. 7 1998 875 883
14. W. Zhou, G. Liu, S.W. Thurston, L.L. Xu, D.P. Miller, and J.C. Wain Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer Cancer Epidemiol. Biomarkers Prev. 11 2002 15 21
15. S.M. Hou, S. Falt, K. Yang, F. Nyberg, G. Pershagen, and K. Hemminki Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls Cancer Epidemiol. Biomarkers Prev. 10 2001 133 140
16. A.M. Tjonneland, and O.K. Overvad [Diet, cancer and health-a population study and establishment of a biological bank in Denmark] Ugeskr. Laeger 162 2000 350 354
17. H.H. Storm The Danish cancer registry: a self-reporting national cancer registration system with elements of active data collection IARC Sci. Publ. 1991 220 236
18. S.S. Tworoger, J. Chubak, E.J. Aiello, C.M. Ulrich, C. Atkinson, and J.D. Potter Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women Cancer Epidemiol. Biomarkers Prev. 13 2004 94 101
19. J.K. Wiencke, M.R. Spitz, A. McMillan, and K.T. Kelsey Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism Cancer Epidemiol. Biomarkers Prev. 6 1997 87 92
20. C. Sachse, G. Smith, M.J. Wilkie, J.H. Barrett, R. Waxman, and F. Sullivan A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer Carcinogenesis 23 2002 1839 1849
21. H. Okkels, T. Sigsgaard, H. Wolf, and H. Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol. Biomarkers Prev. 6 1997 225 231
22. W.E. Barlow, L. Ichikawa, D. Rosner, and S. Izumi Analysis of case-cohort designs J. Clin. Epidemiol. 52 1999 1165 1172
23. W.E. Barlow Robust variance estimation for the case-cohort design Biometrics 50 1994 1064 1072
24. S. Garte, L. Gaspari, A.K. Alexandrie, C. Ambrosone, H. Autrup, and J.L. Autrup Metabolic gene polymorphism frequencies in control populations Cancer Epidemiol. Biomarkers Prev. 10 2001 1239 1248
25. P. Vineis, H. Bartsch, N. Caporaso, A.M. Harrington, F.F. Kadlubar, and M.T. Landi Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature 369 1994 154 156
26. P. Vineis, M. Alavanja, and S. Garte Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation Int. J. Cancer 108 2004 2 7
27. D. Sesardic, M. Pasanen, O. Pelkonen, and A.R. Boobis Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues Carcinogenesis 11 1990 1183 1188
28. D.W. Hein, M.A. Doll, T.D. Rustan, K. Gray, Y. Feng, and R.J. Ferguson Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases Carcinogenesis 14 1993 1633 1638
29. L. Hagmar, S. Bonassi, U. Stromberg, A. Brogger, L.E. Knudsen, and H. Norppa Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH) Cancer Res. 58 1998 4117 4121
30. J.M. Pluth, D.O. Nelson, M.J. Ramsey, and J.D. Tucker The relationship between genotype and chromosome aberration frequencies in a normal adult population Pharmacogenetics 10 2000 311 319